Published in Clin Dev Immunol on March 19, 2012
Impact of Xpert MTB/RIF testing on tuberculosis management and outcomes in hospitalized patients in Uganda. PLoS One (2012) 1.52
Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed HIV-infected adults: a prospective, clinic-based study. BMC Infect Dis (2014) 1.32
Value of urine lipoarabinomannan grade and second test for optimizing clinic-based screening for HIV-associated pulmonary tuberculosis. J Acquir Immune Defic Syndr (2015) 1.10
Identifying potential differences in cause-of-death coding practices across Russian regions. Popul Health Metr (2016) 0.76
Autopsy Prevalence of Tuberculosis and Other Potentially Treatable Infections among Adults with Advanced HIV Enrolled in Out-Patient Care in South Africa. PLoS One (2016) 0.76
Measuring mortality due to HIV-associated tuberculosis among adults in South Africa: Comparing verbal autopsy, minimally-invasive autopsy, and research data. PLoS One (2017) 0.75
Policy to practice: impact of GeneXpert MTB/RIF implementation on the TB spectrum of care in Lilongwe, Malawi. Trans R Soc Trop Med Hyg (2016) 0.75
Rapid urine lipoarabinomannan assay as a clinic-based screening test for active tuberculosis at HIV diagnosis. BMC Pulm Med (2016) 0.75
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet (2006) 21.60
Validation and application of verbal autopsies in a rural area of South Africa. Trop Med Int Health (2000) 5.77
HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med (2009) 4.76
Who dies from what? Determining cause of death in South Africa's rural north-east. Trop Med Int Health (1999) 3.91
The prevalence and drug sensitivity of tuberculosis among patients dying in hospital in KwaZulu-Natal, South Africa: a postmortem study. PLoS Med (2010) 2.86
Tuberculosis in Africa--combating an HIV-driven crisis. N Engl J Med (2008) 2.67
Tuberculosis in HIV-infected patients: a comprehensive review. Clin Microbiol Infect (2004) 2.13
Factors associated with an increased case-fatality rate in HIV-infected and non-infected South African gold miners with pulmonary tuberculosis. Int J Tuberc Lung Dis (2000) 2.02
Cause of death in patients admitted to hospital for pulmonary tuberculosis. Lancet (1983) 1.41
Tuberculosis at Edendale Hospital in Pietermaritzburg, Kwazulu Natal, South Africa. Int J Tuberc Lung Dis (2004) 1.24
Impact of the human immunodeficiency virus epidemic on mortality among adults with tuberculosis in rural South Africa, 1991-1995. Int J Tuberc Lung Dis (1998) 1.10
Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet (2002) 6.54
Overdiagnosis of asthma in obese and nonobese adults. CMAJ (2008) 3.23
Xpert MTB/RIF testing in a low tuberculosis incidence, high-resource setting: limitations in accuracy and clinical impact. Clin Infect Dis (2014) 3.07
Re: The end of veterinary homeopathy. Aust Vet J (2008) 2.98
The prevalence and drug sensitivity of tuberculosis among patients dying in hospital in KwaZulu-Natal, South Africa: a postmortem study. PLoS Med (2010) 2.86
Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes. Clin Infect Dis (2013) 2.02
Pneumocystis jiroveci pneumonia prophylaxis is not required with a CD4+ T-cell count < 200 cells/microl when viral replication is suppressed. AIDS (2007) 1.85
Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis. Clin Infect Dis (2011) 1.83
Patient and provider delay in tuberculosis suspects from communities with a high HIV prevalence in South Africa: a cross-sectional study. BMC Infect Dis (2008) 1.82
Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis. Ann Intern Med (2007) 1.75
Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control. Clin Microbiol Rev (2012) 1.68
CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults. AIDS (2005) 1.68
Respiratory viral coinfections identified by a 10-plex real-time reverse-transcription polymerase chain reaction assay in patients hospitalized with severe acute respiratory illness--South Africa, 2009-2010. J Infect Dis (2012) 1.61
Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis. Int J Epidemiol (2013) 1.57
Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009-2011. Emerg Infect Dis (2013) 1.55
Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS Med (2011) 1.42
Mixed-strain Mycobacterium tuberculosis infections among patients dying in a hospital in KwaZulu-Natal, South Africa. J Clin Microbiol (2010) 1.42
Sex, politics, and religion: why AIDS is a secular issue. J Int Assoc Physicians AIDS Care (Chic) (2004) 1.40
Twenty-five years of AIDS. CMAJ (2006) 1.39
The pharmacokinetics of nelfinavir and M8 during pregnancy and post partum. Clin Pharmacol Ther (2004) 1.33
Effect of alcohol use and highly active antiretroviral therapy on plasma levels of hepatitis C virus (HCV) in patients coinfected with HIV and HCV. Clin Infect Dis (2005) 1.32
Review of the effect of highly active antiretroviral therapy on hepatitis C virus (HCV) RNA levels in human immunodeficiency virus and HCV coinfection. Clin Infect Dis (2002) 1.30
Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response. Vaccine (2004) 1.23
Steady-State pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects. Clin Pharmacokinet (2010) 1.21
Quality of life of patients with advanced HIV/AIDS: measuring the impact of both AIDS-defining events and non-AIDS serious adverse events. J Acquir Immune Defic Syndr (2009) 1.19
HIV Online Provider Education (HOPE): the internet as a tool for training in HIV medicine. J Infect Dis (2007) 1.13
Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa. BMC Infect Dis (2006) 1.07
Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10. AIDS (2002) 1.05
A comparison of obese and nonobese people with asthma: exploring an asthma-obesity interaction. Chest (2010) 1.04
The prevalence of blebs or bullae among young healthy adults: a thoracoscopic investigation. Chest (2007) 1.04
Epidemiology of respiratory syncytial virus-associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children, 2010-2011. J Infect Dis (2013) 1.04
Rapid elimination of Toxoplasma gondii by gamma interferon-primed mouse macrophages is independent of CD40 signaling. Infect Immun (2007) 1.03
A comparison of cases of paediatric-onset and adult-onset cryptococcosis detected through population-based surveillance, 2005-2007. AIDS (2012) 1.02
Time-dependent interaction between lopinavir/ritonavir and fexofenadine. J Clin Pharmacol (2006) 1.02
Alterations in natural killer cell receptor profiles during HIV type 1 disease progression among chronically infected South African adults. AIDS Res Hum Retroviruses (2010) 1.01
Validation of the Accutrend lactate meter for hyperlactatemia screening during antiretroviral therapy in a resource-poor setting. Int J Infect Dis (2008) 1.01
Multidrug-resistant tuberculous meningitis in children in Durban, South Africa. Pediatr Infect Dis J (2006) 0.99
Development and validation of the HIV Medication Readiness Scale. Assessment (2007) 0.97
Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use. AIDS (2006) 0.97
The role of psychological and behavioral variables in quality of life and the experience of bodily pain among persons living with HIV. J Pain Symptom Manage (2008) 0.97
HIV and influenza virus infections are associated with increased blood pneumococcal load: a prospective, hospital-based observational study in South Africa, 2009-2011. J Infect Dis (2013) 0.96
Impact of blood processing variations on natural killer cell frequency, activation, chemokine receptor expression and function. J Immunol Methods (2011) 0.96
Low-income Canadians' experiences with health-related services: implications for health care reform. Health Policy (2005) 0.96
Epidemiology of influenza virus types and subtypes in South Africa, 2009-2012. Emerg Infect Dis (2014) 0.96
Utility of biomarkers in the differential diagnosis of heart failure in older people: findings from the heart failure in care homes (HFinCH) diagnostic accuracy study. PLoS One (2013) 0.95
Systematic review of the effectiveness of training programs in writing for scholarly publication, journal editing, and manuscript peer review (protocol). Syst Rev (2013) 0.95
Vacuolar myelopathy: a case report of functional, clinical, and radiological improvement after highly active antiretroviral therapy. Int J Infect Dis (2007) 0.90
Epidemiology of viral-associated acute lower respiratory tract infection among children <5 years of age in a high HIV prevalence setting, South Africa, 2009-2012. Pediatr Infect Dis J (2015) 0.90
Preliminary analysis of polyhydroxyalkanoate inclusions using atomic force microscopy. FEMS Microbiol Lett (2003) 0.89
Circasemiannual chronomics: half-yearly biospheric changes in their own right and as a circannual waveform. Biomed Pharmacother (2003) 0.89
Feasibility of evidence-based diagnosis and management of heart failure in older people in care: a pilot randomised controlled trial. BMC Geriatr (2012) 0.88
Pharmacokinetic and pharmacodynamic modeling of humanized anti-factor IX antibody (SB 249417) in humans. Clin Pharmacol Ther (2002) 0.88
Pediatric critical care medicine: planning for our research future. Pediatr Crit Care Med (2003) 0.88
Use of intravenous immunoglobulin for treatment of neurologic conditions: a systematic review. Transfusion (2005) 0.88
Inhibition of human cytochrome p450 metabolism by blended herbal products and vitamins. J Pharm Pharm Sci (2011) 0.87
Prolonged deferral of antiretroviral therapy in the SAPIT trial: did we need a clinical trial to tell us that this would increase mortality? S Afr Med J (2010) 0.87
Timing of antiretroviral drugs during tuberculosis therapy. N Engl J Med (2010) 0.87
Application of an algorithm to predict CD4 lymphocyte count below 200 cells/mm(3) in HIV-infected patients in South Africa. AIDS (2004) 0.85
Connection domain mutations in treatment-experienced patients in the OPTIMA trial. J Acquir Immune Defic Syndr (2010) 0.85
A comparison of wet-dry swabbing and excision sampling methods for microbiological testing of bovine, porcine, and ovine carcasses at red meat slaughterhouses. J Food Prot (2005) 0.84
Lymphocyte mitochondrial depolarization and apoptosis in HIV-1-infected HAART patients. J Acquir Immune Defic Syndr (2008) 0.83
Characteristics, treatment, and antiretroviral prophylaxis adherence of South African rape survivors. J Acquir Immune Defic Syndr (2007) 0.83
Results of antiretroviral treatment interruption and intensification in advanced multi-drug resistant HIV infection from the OPTIMA trial. PLoS One (2011) 0.82
The Feasibility, Accuracy, and Impact of Xpert MTB/RIF Testing in a Remote Aboriginal Community in Canada. Chest (2015) 0.81
Cost-effectiveness of newer antiretroviral drugs in treatment-experienced patients with multidrug-resistant HIV disease. J Acquir Immune Defic Syndr (2013) 0.80
Promoting participation: evaluation of a health promotion program for low income seniors. J Community Health Nurs (2003) 0.80
Health of prisoners, and the public health: no man is an island. J Int Assoc Physicians AIDS Care (Chic) (2004) 0.80
A 4-year sequential assessment of the Families First Edmonton partnership: challenges to synergy in the implementation stage. Health Promot Pract (2011) 0.80
AIDS-related mycoses: the way forward. Trends Microbiol (2014) 0.80
Epidemiology of Serotype 1 Invasive Pneumococcal Disease, South Africa, 2003-2013. Emerg Infect Dis (2016) 0.79
Generic antiretroviral efficacy in AIDS-associated Kaposi's sarcoma in sub-Saharan Africa. AIDS (2005) 0.79
Attenuated Salmonella typhimurium SL3261 as a vaccine vector for recombinant antigen in rabbits. J Immunol Methods (2005) 0.79
In vitro and in vivo activity of combination antimicrobial agents on Haemophilus ducreyi. J Antimicrob Chemother (2005) 0.79
Oral antibiotic therapy for the treatment of infective endocarditis: a systematic review. BMC Infect Dis (2014) 0.79
High HIV knowledge relates to low stigma in pharmacists and university health science students in Guyana, South America. Int J Infect Dis (2010) 0.79
Effect of treatment interruption and intensification of antiretroviral therapy on health-related quality of life in patients with advanced HIV: a randomized, controlled trial. Med Decis Making (2011) 0.79
Interaction studies of tipranavir-ritonavir with clarithromycin, fluconazole, and rifabutin in healthy volunteers. Antimicrob Agents Chemother (2008) 0.78
About 21-year hale cyclic signature in agriculture complement those in biomedicine. Biomed Pharmacother (2004) 0.78
Effect of GB virus C co-infection on response to generic HAART in African patients with HIV-1 clade C infection. AIDS (2007) 0.78
HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal. PLoS One (2011) 0.78
Probing acid replacements of thiophene PTP1B inhibitors. Bioorg Med Chem Lett (2007) 0.78
Design and methods of the MAINTAIN study: a randomized controlled clinical trial of micronutrient and antioxidant supplementation in untreated HIV infection. Contemp Clin Trials (2010) 0.78
Chronobiology and chronomics: detecting and applying the cycles of nature. Biologist (London) (2009) 0.78
Stavudine-induced hyperlactatemia/lactic acidosis at a tertiary communicable diseases clinic in South Africa. J Int Assoc Physicians AIDS Care (Chic) (2010) 0.78
Interpretation of undetectable hepatitis C virus RNA levels in HIV-hepatitis C virus co-infection. AIDS (2004) 0.78
The tuberculosis and HIV epidemic in South Africa and the KwaZulu-Natal Research Institute for Tuberculosis and HIV. J Infect Dis (2011) 0.78
Singh's verbal autopsy questionnaire for the assessment of causes of death, social autopsy, tobacco autopsy and dietary autopsy, based on medical records and interview. Acta Cardiol (2011) 0.77
Use of signature-tagged mutagenesis to identify virulence determinants in Haemophilus ducreyi responsible for ulcer formation. J Microbiol Methods (2010) 0.77
Genetic diversity and molecular epidemiology of human rhinoviruses in South Africa. Influenza Other Respir Viruses (2014) 0.77
System times and time horizons for biospheric near-matches of primarily non-photic environmental cycles. Biomed Pharmacother (2002) 0.77
Polymorphisms in the gene that encodes the iron transport protein ferroportin 1 influence susceptibility to tuberculosis. J Infect Dis (2012) 0.77
Hormone replacement therapy is associated with gastro-oesophageal reflux disease: a retrospective cohort study. BMC Gastroenterol (2012) 0.77
Tuberculosis elimination in the Canadian First Nations population: assessment by a state-transfer, compartmental epidemic model. Int J Infect Dis (2009) 0.77
Nutritional aspects of epigenetic inheritance. Can J Physiol Pharmacol (2012) 0.77
Effect of resveratrol on exercise capacity: a randomized placebo-controlled crossover pilot study. Appl Physiol Nutr Metab (2014) 0.76